Teligent Long Term Debt 2010-2021 | TLGT

Teligent long term debt from 2010 to 2021. Long term debt can be defined as the sum of all long term debt fields.
Teligent Annual Long Term Debt
(Millions of US $)
2020 $162
2019 $186
2018 $140
2017 $121
2016 $111
2015 $103
2014 $145
2013 $3
2012 $1
2011 $1
2010 $0
2009 $
Teligent Quarterly Long Term Debt
(Millions of US $)
2021-06-30 $117
2021-03-31 $114
2020-12-31 $162
2020-09-30 $199
2020-06-30 $196
2020-03-31 $190
2019-12-31 $186
2019-09-30 $159
2019-06-30 $156
2019-03-31 $147
2018-12-31 $140
2018-09-30 $118
2018-06-30 $130
2018-03-31 $124
2017-12-31 $121
2017-09-30 $118
2017-06-30 $116
2017-03-31 $114
2016-12-31 $111
2016-09-30 $113
2016-06-30 $111
2016-03-31 $109
2015-12-31 $103
2015-09-30 $105
2015-06-30 $107
2015-03-31 $138
2014-12-31 $145
2014-09-30 $3
2014-06-30 $3
2014-03-31 $3
2013-12-31 $3
2013-09-30 $3
2013-06-30 $2
2013-03-31 $2
2012-12-31 $1
2012-09-30 $1
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $1
2011-03-31 $1
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00